According to one study, depressed COVID patients respond better to antidepressants

In a pilot study, depressed patients who had Covid responded better to standard antidepressants than those who did not have Covid.

The findings of the study have been published in the journal “European Neuropsychopharmacology.”

Within six months of infection, over 40% of covid patients report developing depression. The inflammation generated by covid is thought to be the primary factor in the onset of depression. New research has discovered that roughly 90% of patients with covid respond to SSRIs, which is substantially higher than previously thought.

“We know that covid led to an epidemic of mental health disorders,” stated Mario Mazza, MD, of San Raffaele University in Milano. Although post-covid depression is a severe problem, with approximately 40% of covid patients experiencing depression within 6 months of infusion, this study suggests that people who have received covid have a greater chance of managing their depression than previously assumed.

Professor Francesco Benedetti’s psychiatry and clinical psychobiology laboratory at San Raffaele Hospital in Milano treated 58 patients with SSRIs who had acquired post-covid depression.